Accueil>>Signaling Pathways>> Microbiology & Virology>> Parasite>>Nerolidol

Nerolidol (Synonyms: (±)-Nerolidol)

Catalog No.GC41343

Le nérolidol est un sesquiterpène naturel actif sur la membrane, avec une activité antitumorale, antibactérienne, antifongique et antiparasitaire.

Products are for research use only. Not for human use. We do not sell to patients.

Nerolidol Chemical Structure

Cas No.: 7212-44-4

Taille Prix Stock Qté
10g
38,00 $US
En stock
25g
51,00 $US
En stock
50g
95,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nerolidol is a sesquiterpene found in a variety of plants, including C. sativa, that has diverse biological activities, including antioxidant, anthelmintic, antinociceptive, and anti-inflammatory properties. It decreases superoxide dismutase (SOD) and catalase activity, reduces glutathione (GSH) levels, and increases malondialdehyde (MDA) levels in the brain when administered at a dose of 50 mg/kg in a rat model of Parkinson's disease induced by rotenone . It also inhibits rotenone-induced increases in IL-1β, IL-6, and TNF-α in rat brain. Nerolidol (100, 200, and 400 mg/kg) reduces worm burden and egg production in a mouse model of schistosomiasis. It also decreases acetic acid-induced writhing and formalin-induced licking time in mice, indicating antinociceptive activity, and reduced carrageenan-induced paw edema when administered at doses of 300 and 400 mg/kg. Formulations containing nerolidol have been used as fragrance ingredients.

Avis

Review for Nerolidol

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nerolidol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.